Yu, Kaohsiung
Bi Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20150297647 | ENTEROCOCCUS FAECIUM EF08 STRAIN, A USE, A FEED ADDITIVE AND A FEED THEREOF | 10-22-2015 |
Hsin-Su Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20120215120 | NONINVASIVE CUTANEOUS BLOOD FLOW ASSESSMENT AS A RESPONSE PREDICTOR FOR VISIBLE LIGHT THERAPY ON SEGMENTAL VITILIGO - Visible light is a treatment option for Segmental Vitiligo (SV), and visible light-induced repigmentation is associated normalization of sympathetic. Currently it is difficult to predict individual patient's response to visible light therapy. Therefore, the present invention uses the Laser Doppler Flowmeter to serve as a response predictor for visible light on treating SV. The present invention recruited 14 Segmental Vitiligo patients for evaluating clinical information. FirstLaser Doppler Flowmeter was used to evaluate the cutaneous blood flow of SV lesion and contralateral normal skin, and then treated them with visible light irradiate, cold-stress, rewarmed, and recorded the change of skin blood flow, finally the patients received regular visible light treatment for 3 months, and patients have a sign of repigmentation after the treatment. | 08-23-2012 |
20130053699 | APPARATUS AND METHOD FOR PERFORMING PHOTODYNAMIC DIAGNOSIS AND PHOTODYNAMIC THERAPY - An apparatus for performing photodynamic diagnosis and photodynamic therapy on a target region that is pre-given with a photosensitizer precursor includes a display unit, an excitation light source operable to irradiate the target region with exciting light so as to excite emission of fluorescence from the target region as a result of fluorescence response of the photosensitizer precursor, an image capturing unit operable to capture a white light image and a fluorescent image of the target region, an image processing unit operable to superimpose the white light image and the fluorescent image into a synthesized image and to provide at least one of the white light image, the fluorescent image and the synthesized image thereto for display on the display unit, and a curing light source operable to irradiate a specified portion of the target region with curing light for treating the specified portion. | 02-28-2013 |
James Chein-Chih Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20090317424 | Oral vaccines - This invention features a composition that includes a multiple-cell organism for use as food for an aquatic animal (e.g., a fish or a shrimp), and a single-cell organism fed to, and as a result, bioencapsulated by, the multiple-cell organism. The single-cell organism has been transformed to express a recombinant antigen that induces an immune response in the aquatic animal. | 12-24-2009 |
Jui-I Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20080308938 | Under bump metallurgy structure and wafer structure using the same and method of manufacturing wafer structure - An under bump metallurgy structure and wafer structure using the same and method of manufacturing wafer structure are provided. The under bump metallurgy structure includes an adhesion layer, a barrier layer and a wetting layer. The adhesion layer is disposed on a bonding pad of a wafer. The barrier layer is disposed on the adhesion layer. The wetting layer is disposed on the barrier layer. The adhesion layer, the barrier layer and the wetting layer are respectively made of nickel with boron, cobalt and gold. | 12-18-2008 |
Kei-Chien Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20090191009 | WATER AND SOIL CONSERVATION METHOD AND A RETAINING WALL FOR PERFORMING THE SAME - A retaining wall for water and soil conservation use a plurality of stacking retaining plates. Each of the retaining plate has a plurality of inner protrusions at an inner side thereof. The protrusions of the lower retaining plate of the stacking retaining plates grab the soil at the bottom of the slopeland so as to form a steady retaining structure. The method for performing the water and soil conservation by the wall is also disclosed. | 07-30-2009 |
20090278102 | PROTECTION BARRIER - A protection barrier includes a base, the base having a great lower side and a small topside; the base expanding from the topside to the lower side gradually; each of two lateral sides of the base being installed with a first buffer for buffering and resisting impacts from vehicles. The base has an approximate triangle shape with each apex being frustrated. Each of the two lateral sides of the base having a second buffer. A ground anchor is installed to a bottom of the base. The buffers have a shape selected from semi-round shapes, semi-elliptical shapes, and other cambered shapes. The protection barriers can be arranged longitudinally between two lanes for isolation or aside a lane for preventing a vehicle to run out of the lane. | 11-12-2009 |
20120014747 | ECOLOGICAL BOARD AND ITS APPLICATIONS - An ecological board includes a quadrilateral board body, on the side edges thereof is disposed at least one reglet or at least one insertion groove to be engaged with a corresponding insertion groove or a reglet of another identical board body. Further, a plurality of separated strong and pliable pad bodies are embedded in at least a first side surface of the board body and protrude outwards therefrom. The ecological board according to the present invention is durable, stable, easy to construct, maintain, and repair, and environmentally friendly to the natural landscape. Most importantly, it can be applied to various environments, such as coastlines, artificial reefs, and slopes of reservoirs, rivers, or mountains. | 01-19-2012 |
Lin-Wang Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20100237490 | PACKAGE STRUCTURE AND MANUFACTURING METHOD THEREOF - A package structure and a manufacturing method thereof are provided. The package structure includes a packaging substrate, a chip, an interposer substrate, a wire and an adhesive layer. The packaging substrate has an upper packaging surface. The chip is disposed on the upper packaging surface. The wire connects the packaging substrate and the interposer substrate. The adhesive layer is disposed between the packaging substrate and the interposer substrate, and covers the entire chip and part of the upper packaging surface. The adhesive layer includes a first adhesive part and a second adhesive part. The first adhesive part adheres the interposer substrate and the chip. The second adhesive part surrounds the first adhesive part, adheres the interposer substrate and the packaging substrate, and supports a periphery of the interposer substrate. | 09-23-2010 |
Pin-Chih Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20150291732 | MODIFIED PHOSPHORUS-CONTAINING UNSATURATED POLYESTER - A modified phosphorus-containing unsaturated polyester being represented by Formula I is provided: | 10-15-2015 |
20150291740 | FLAME-RETARDANT POLYESTER - The present invention is directed to a flame-retardant polyester having a structure of formula (1): | 10-15-2015 |
Tien-Wei Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20140070377 | COMPOUND SEMICONDUCTOR EPITAXIAL STRUCTURE AND METHOD FOR FABRICATING THE SAME - A method for fabricating a compound semiconductor epitaxial structure includes the following steps. Firstly, a first compound epitaxial layer is formed on a substrate. Then, a continuous epitaxial deposition process is performed to form a second compound epitaxial layer on the first compound epitaxial layer, so that the second compound epitaxial layer has a linearly-decreased concentration gradient of metal. Afterwards, a semiconductor material layer is formed on the second compound epitaxial layer. | 03-13-2014 |
Tsung-Chih Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20140188047 | THERMOTHERAPY NEEDLING INSTRUMENT WITH TISSUE INJECTION - The disclosure provides a thermotherapy needling instrument with tissue injection, including: a casing, an outer needle, an inner needle and a working needle. The casing has an inlet, an outlet and an inner channel. The outer needle is connected to the casing, and is in communication with the inner channel. The inner needle is disposed in the inner channel of the casing and the outer needle, and the inner needle has at least one opening The at least one opening is in communication with the inner channel so that the cooling agent flows in circulation. The working needle is connected to the outer needle so as to receive the injectant for injection and tissue ablation. By using the thermotherapy needling instrument, when sampling or injection is required during thermotherapy, the injection efficacy can be achieved by withdrawing the inner needle only. Therefore, efficacy of tissue injection and ablation thermotherapy can be achieved. | 07-03-2014 |
Wei-Tai Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20120215120 | NONINVASIVE CUTANEOUS BLOOD FLOW ASSESSMENT AS A RESPONSE PREDICTOR FOR VISIBLE LIGHT THERAPY ON SEGMENTAL VITILIGO - Visible light is a treatment option for Segmental Vitiligo (SV), and visible light-induced repigmentation is associated normalization of sympathetic. Currently it is difficult to predict individual patient's response to visible light therapy. Therefore, the present invention uses the Laser Doppler Flowmeter to serve as a response predictor for visible light on treating SV. The present invention recruited 14 Segmental Vitiligo patients for evaluating clinical information. FirstLaser Doppler Flowmeter was used to evaluate the cutaneous blood flow of SV lesion and contralateral normal skin, and then treated them with visible light irradiate, cold-stress, rewarmed, and recorded the change of skin blood flow, finally the patients received regular visible light treatment for 3 months, and patients have a sign of repigmentation after the treatment. | 08-23-2012 |
You-Qing Yu, Kaohsiung TW
Patent application number | Description | Published |
---|---|---|
20160058722 | METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES - A method for improving the oxygen-releasing ability of hemoglobin to organs and peripheral tissues in human bodies is disclosed by administering ferulic acid to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin to the organs and the peripheral tissues in human bodies. Ferulic acid forms a hydrogen bond with αVal1 of hemoglobin, stabilizing the α1/α2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues. | 03-03-2016 |
20160058732 | METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES AND A MEDICATION THEREOF - A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to organs and peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to the organs and the peripheral tissues in human bodies. The compound of phthalides is characterized by a phthalide functional group, and forms at least one hydrogen bond with αArg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes, stabilizing the α1/α2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues. A medication for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin, and hemoglobin-based blood substitutes to organs and peripheral tissues in human bodies is also disclosed. | 03-03-2016 |